Described is a technique for characterizing the disease state of excised tissue, such as a tumor removed by a biopsy procedure, which uses RT-PCR techniques to identify one or more target genes in multiple discrete portions of the tumor, resulting in a graphical or digital representation of the target genes across the tissue sample being studied.
PCR (Polymerase Chain Reaction) is a technique used in molecular genetics that permits the analysis of any short sequence of DNA (or RNA) without having to clone it. PCR is used to reproduce (amplify) selected sections of DNA. Previously, the amplification procedure which utilized bacteria took weeks. Using PCR the procedure is performed in test tubes and takes only a few hours. PCR is highly efficient so that a large numbers of copies of the DNA can be made. In addition, PCR uses the same molecules that nature uses for copying DNA:
Three major steps are involved in the PCR procedure and these three steps are repeated numerous times, for example 30 or 40 cycles. The cycles are performed using an automated cycler, which rapidly heats and cools the test tubes containing the reaction mixture so that each of the steps can be performed in the intended order. Each of the steps, namely denaturation (alteration of structure), annealing (joining), and extension, takes place at a different temperature:
Because PCR does not require that the original DNA be copied to be pure or abundant, PCR has found widespread and innumerable uses. These uses include but are not limited to diagnosing genetic diseases, conducting DNA fingerprinting, finding bacteria and viruses, studying human evolution, cloning the DNA of an Egyptian mummy, etc. As a result PCR has become an essential tool for biologists, DNA forensics labs and many other laboratories that work with genetic material.
Kary Mullis, the inventor of PCR, has written in the Scientific American: “Beginning with a single molecule of the genetic material DNA, the PCR can generate 100 billion similar molecules in an afternoon. The reaction is easy to execute. It requires no more than a test tube, a few simple reagents, and a source of heat.”
RT-PCR (Reverse transcriptase-polymerase chain reaction) is a highly sensitive technique for the detection and quantification of mRNA (messenger RNA). The technique consists of two parts:
1) The synthesis of cDNA (complementary DNA) from RNA by reverse transcription (RT), and
2) The amplification of a specific cDNA by the polymerase chain reaction (PCR). RT-PCR has been approved by the FDA as a test to measure viral load with HIV. It may also be used with other RNA viruses such as measles, mumps, and metapneumovirus.
Scientists have developed RT-PCR tests for use on biopsy samples to detect tumor gene expression (RNA) and genetic markers (DNA) that are signatures of specific tumor cells in cancer patients. It is also possible to directly analyze the DNA obtained from a small amount of paraffin-embedded tumor tissue sections (20 microns) by Laser Capture Microdissection (LCM). The LCM allows the assessment of less than about 50 tumor cells cut out from a tumor lesion and determine their molecular profile. (Takeuchi H, Morton D L, Kuo C, Turner R R, Elashoff D, Elashoff R, Taback B, Fujimoto A, Hoon D S B. “Prognostic Significance Of Molecular Upstaging Of Paraffin-Embedded Sentinel Lymph Nodes In Melanoma Patients, J. Clin. Oncol., 22, pp2671-2680 (2004). The normal technique is to profile a biopsy sample by subjecting the whole sample to analysis to identify multiple different genes in the sample.
The invention is directed to showing the profile of one or more genes across the tissue sample. Tissue removed from the body is sliced in to thin sheets and those sheets are then divided into small portions each portion being identified as to a location in the sheet. The image of the thin slice and the position of each small portion thereof is recorded in a computer in a manner that can generate an image of the slice. Each small portion is subject to RT-PCR to identify the presence and quantity of one or more genes therein. The portion-specific data is then entered into the computer and an image of the slice is generated showing the gene specific characteristics of each small portion. The result is a parametric image of the entire slice which allows the visualization of the gene expression within each portion which can then be compared with other images of the same or adjacent tissue.
A purpose of the invention is to provide a parametric image of a tissue sample, with the gray scale of the image representing the level of one or more particular genes expressed as measured by RT-PCR, for comparison with other types of images of the same or adjacent slices of the tissue sample. Superimposing or comparing these parametric images on or with the stained microscopic images of the same or adjacent slice will reveal important biological information. In addition, if the living subject was injected with a radio-labeled tracer, the auto-radiography of slices can be superimposed, revealing correlations between gene expression and uptake of various radio-tracers. Thus, the information obtained from the parametic images of gene expression can be of utility in biological research, drug discovery, and study of tissue samples in biopsy of cancer patients, neurological disorders, or other diseases. Also, in this manner the stage of the tumor can be readily ascertained and active margins can be determined.
Another application of this invention is in bio-medical research involving laboratory animals. For example the uptake of F-18 deoxy-glucose can be mapped using autoradiography in a tissue slice, and then using the parametic image of gene expression, one can study the correlation of different genes (such as glucose transporter gene GLUT-1) with the uptake of flouro-deoxy-glucose.
As an example of the procedure:
This application claims the benefit of U.S. Provisional Application No. 60/752,348, filed Dec. 20, 2005.
| Number | Date | Country | |
|---|---|---|---|
| 60752348 | Dec 2005 | US |